Lee Ainslie's Strategic Moves in Q1 2024: A Deep Dive into Coupang Inc's Significant Reduction
Insights from Maverick Capital's Latest 13F Filing
Stay updated with breaking news from Immunogen Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insights from Maverick Capital's Latest 13F Filing
Antibody-drug conjugate (ADC) is a promising class of cancer treatments with accelerating U.S. Food and Drug Administration (FDA) approval and rapidly growing market size as discussed...
AbbVie Inc is expected to report $1.14 for 1Q. Advent Technologies Holdings Inc is expected to report for 4Q. AutoNation is expected to report $4.39 for 1Q. Avantor Inc is expected... -April 26, 2024 at 06:26 am EDT - MarketScreener
NEWTON SQUARE, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of
Lisa Janssen Carlson, PharmD, BCOP, discusses some background and history of regulations for the conduct of clinical trials.